DMT1 blocker 2 is primarily used in research settings to study iron metabolism and related pathways. It inhibits the function of DMT1 (divalent metal transporter 1), a key protein involved in the transport of iron and other divalent metals across cell membranes. By blocking DMT1, researchers can investigate the role of iron uptake in various biological processes, including cellular iron homeostasis, oxidative stress, and the development of iron-related disorders such as anemia or iron overload. This compound is also valuable in exploring potential therapeutic strategies for conditions linked to dysregulated iron metabolism. Its application extends to understanding the broader implications of metal transport in neurodegenerative diseases, where iron dysregulation is often implicated.